Abstract:OBJECTIVE:To evaluate the protective efficacy against a lethal dose of E. coli O157:H7 after intranasal, oral and subcutaneous immunization with the outer membrane protein (OMP) extracted from the whole cell of E. coli O157:H7.METHODS:Female BALB/C mice were immunized three times (on days 0, 7 and 14) with OMP and CT or Complete Frund adjuvant. On the 21st day after the last immunization, serum, fecal extracts and vaginal washes were collected for the detection of antigen-specific antibody responses by ELISA before the oral challenge with E. coli O157:H7 933. And the antigens that induced the specific antibody responses were analysed by Western-blotting. Then, the mice were orally challenged with 0.3 ml 4.25 x 10(10)/ml live E. coli O157:H7, and the mortality was recorded. On the 7th day after the challenge, the mice were sacrificed and the heart, liver, lung, kidney, small intestine and colon were collected. Then the histology lesions were observed by light microscopy.RESULTS:In ELISA, both intranasal and oral immunization, with CT as a mucosal adjuvant, induced strong anti-OMP IgA responses in serum, fecal extract and vaginal washes, and anti-OMP IgG responses in serum. However, the intranasal immunization was much more effective to induce specific IgA and IgG responses than the oral immunization. In contrast to mucosal immunization, subcutaneous immunization only induced high levels of specific IgG antibodies in serum, and did not effectively promote IgA immune response. The results of the protective efficacy after challenge showed that both intranasal and oral immunizations with OMP provided significant protection (86.7% to 40%, P < 0.01 and 73.3% to 40%, P < 0.05) against a lethal dose of E. coli O157:H7 challenge, and intranasal immunization possessed a better protective ability (86.7% to 73.3%, P < 0.05). In contrast, the mice immunized subcutaneously were not protected. They were died more early after oral challenge. Furthermore, the histopathological features of the kidney, colon and other organs also appeared to be well correlated with immunization route. In comparison with the mice immunized subcutaneously and those in control group, the severity of the histopathological lesions in the tissues of the mice immunized intranasally was minimal.CONCLUSION:These results suggested that the intranasal immunization should be the best choice of vaccine development against E. coli O157:H7.

Immune effect in mice administered orally with recombinant Bacillus subtilis spores expressing OmpC of Salmonella pullorum by using CotB as a fusion partner

Surface Display of OmpC of Salmonella Serovar Pullorum on Bacillus Subtilis Spores

Evaluation of application of recombinant Bacillus Subtilis expressing Salmonella pullorum OmpC gene in broiler chickens

Efficacy of <i>Bacillus methylotrophicus</i> SY200 strain as feed additive against experimental <i>Salmonella typhimurium</i> infection in mice

Effect of Recombinant Bacillus Subtilis SE1 on the Growth, Antioxidant Capacity and Immune Function of Broilers.

Subcutaneous Vaccination With Attenuated Salmonella Enterica Serovar Choleraesuis C500 Expressing Recombinant Filamentous Hemagglutinin And Pertactin Antigens Protects Mice Against Fatal Infections With Both S-Enterica Serovar Choleraesuis And Bordetella Bronchiseptica

Immunogenicity And Cross-Protective Efficacy Induced By Outer Membrane Proteins From Salmonella Typhimurium Mutants With Truncated Lps In Mice

Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus

Prokaryotic Expression of Salmonella Paratyphi A Nmpc Gene and Immunoprotective Effect of the Expressed Product

Outer Membrane Vesicles Derived from Salmonella Typhimurium Mutants with Truncated LPS Induce Cross-Protective Immune Responses Against Infection of Salmonella Enterica Serovars in the Mouse Model.

Protective effects of a supernatant factor from Salmonella typhimurium on Salmonella typhimurium infection of inbred mice

Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid

Reversible Synthesis of Colanic Acid and O-antigen Polysaccharides in Salmonella Typhimurium Enhances Induction of Cross-Immune Responses and Provides Protection Against Heterologous Salmonella Challenge.

Effect of Dietary Bacillus Coagulans Supplementation on Growth Performance and Immune Responses of Broiler Chickens Challenged by Salmonella Enteritidis

Immuno-protection of Intimin and Tir-Tccp Recombinant Protein of Enterohaemorrhagic Escherichia Coli O157 : H7 to Balb/c Mice

Protective Immunity in Mice Induced by EHEC O157 △ Ler/stx (Pbr322::stx1/2b::eae)

Recombinant PorA, the Major Outer Membrane Protein of Campylobacter jejuni, Provides Heterologous Protection in an Adult Mouse Intestinal Colonization Model

Protective immunity of mouse against recombinant membrane protein expressed on Mycobacterium smegmatis

[The Study for the Immuno-Protection of E. Coli O157:H7 Outer Membrane Protein].

Preclinical evaluation of OMVs as potential vaccine candidates against Salmonella enterica serovar Enteritidis infection

Outer Membrane Vesicles Derived from Salmonella Enteritidis Protect against the Virulent Wild-Type Strain Infection in a Mouse Model